IVACC — Intervacc AB Share News
0.000.00%
Last trade - 00:00- SEK443.06m
- SEK297.43m
- SEK20.09m
Brief: Intervacc Q1 EBITDA Loss Widens To SEK 4 Million
Brief: Intervacc AB Gets Funds From Vinnova To Develop New Vaccine
Brief: Intervacc Rights Issue Oversubscribed
Brief: Intervacc Unit To Renegotiate Agreement With IDT Biologika
Brief: Intervacc Q4 Net Revenue Down At Sek 3.0 Million
Brief: Intervacc: Progress In Development Of New Vaccine Against Staphylococcus Aureus Infections
Brief: Intervacc Q3 EBITDA Swings To Loss Of SEK 0.9 Million
Brief: Intervacc enters into a commercial production phase with Strangvac
Brief: Intervacc Q2 EBITDA result turns to loss of SEK 0.3 mln